Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Characterization of HIV-1 genotypes and antiretroviral drug-resistance mutations among patients in Burkina Faso.

Kagone TS, Hien H, Meda N, Diagbouga PS, Sawadogo A, Drabo J, Peeters M, Vergne L, Delaporte E, De Souza C, Gbeassor M, Simpore J.

Pak J Biol Sci. 2011 Mar 15;14(6):392-8.

PMID:
21902063
[PubMed - indexed for MEDLINE]
2.

Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.

Nadembega WM, Giannella S, Simpore J, Ceccherini-Silberstein F, Pietra V, Bertoli A, Pignatelli S, Bellocchi MC, Nikiema JB, Cappelli G, Bere A, Colizzi V, Perno CP, Musumeci S.

J Med Virol. 2006 Nov;78(11):1385-91.

PMID:
16998878
[PubMed - indexed for MEDLINE]
3.

HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina Faso.

Tebit DM, Sangaré L, Makamtse A, Yameogo S, Somlare H, Bado G, Kouldiaty BG, Sathiandee K, Tiba F, Sanou I, Ouédraogo-Traoré R, Zoungrana L, Diallo I, Drabo JY, Kräusslich HG.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):17-25. doi: 10.1097/QAI.0b013e318182d2bc.

PMID:
18667925
[PubMed - indexed for MEDLINE]
4.

Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.

Tebit DM, Sangaré L, Tiba F, Saydou Y, Makamtse A, Somlare H, Bado G, Kouldiaty BG, Zabsonre I, Yameogo SL, Sathiandee K, Drabo JY, Kräusslich HG.

J Med Virol. 2009 Oct;81(10):1691-701. doi: 10.1002/jmv.21600.

PMID:
19697403
[PubMed - indexed for MEDLINE]
5.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
[PubMed - indexed for MEDLINE]
6.

Genetic polymorphisms and resistance mutations of HIV type 2 in antiretroviral-naive patients in Burkina Faso.

Ruelle J, Sanou M, Liu HF, Vandenbroucke AT, Duquenne A, Goubau P.

AIDS Res Hum Retroviruses. 2007 Aug;23(8):955-64.

PMID:
17725411
[PubMed - indexed for MEDLINE]
7.

Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso.

Sylla M, Chamberland A, Boileau C, Traoré HA, Ag-Aboubacrine S, Cissé M, Koala S, Drabo J, Diallo I, Niamba P, Tremblay-Sher D, Machouf N, Rashed S, Nickle DC, Nguyen VK, Tremblay CL; ATARAO Group.

Antivir Ther. 2008;13(1):141-8.

PMID:
18389909
[PubMed - indexed for MEDLINE]
8.

Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children.

Almeida FJ, Berezin EN, Rodrigues R, Sáfadi MA, Arnoni MV, Oliveira C, Brígido LF.

J Pediatr (Rio J). 2009 Mar-Apr;85(2):104-9. doi: doi:10.2223/JPED.1877. English, Portuguese.

PMID:
19319446
[PubMed - indexed for MEDLINE]
Free Article
9.

Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.

Rodes B, García F, Gutierrez C, Martinez-Picado J, Aguilera A, Saumoy M, Vallejo A, Domingo P, Dalmau D, Ribas MA, Blanco JL, Pedreira J, Perez-Elias MJ, Leal M, de Mendoza C, Soriano V; Red de Investigación en SIDA.

J Med Virol. 2005 Sep;77(1):23-8.

PMID:
16032728
[PubMed - indexed for MEDLINE]
10.

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.

Vergne L, Kane CT, Laurent C, Diakhaté N, Gueye NF, Gueye PM, Sow PS, Faye MA, Liégeois F, Ndir A, Lanièce I, Peeters M, Ndoye I, Mboup S, Delaporte E.

AIDS. 2003 Jul;17 Suppl 3:S31-8.

PMID:
14565607
[PubMed - indexed for MEDLINE]
11.

Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.

Yaotsè DA, Nicole V, Roch NF, Mireille PD, Eric D, Martine P.

Infect Genet Evol. 2009 Jul;9(4):646-52. doi: 10.1016/j.meegid.2009.04.002. Epub 2009 Apr 15.

PMID:
19460333
[PubMed - indexed for MEDLINE]
12.

Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.

Weidle PJ, Downing R, Sozi C, Mwebaze R, Rukundo G, Malamba S, Respess R, Hertogs K, Larder B, Ochola D, Mermin J, Samb B, Lackritz E.

AIDS. 2003 Jul;17 Suppl 3:S39-48.

PMID:
14565608
[PubMed - indexed for MEDLINE]
13.

HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy.

Lihana RW, Khamadi SA, Lubano K, Lwembe R, Kiptoo MK, Lagat N, Kinyua JG, Okoth FA, Songok EM, Makokha EP, Ichimura H.

AIDS Res Hum Retroviruses. 2009 Dec;25(12):1211-7. doi: 10.1089/aid.2009.0007.

PMID:
19954302
[PubMed - indexed for MEDLINE]
14.

High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.

Richard N, Juntilla M, Abraha A, Demers K, Paxinos E, Galovich J, Petropoulos C, Whalen CC, Kyeyune F, Atwine D, Kityo C, Mugyenyi P, Arts EJ.

AIDS Res Hum Retroviruses. 2004 Apr;20(4):355-64.

PMID:
15157354
[PubMed - indexed for MEDLINE]
15.

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.

Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.

J Med Virol. 2004 Jul;73(3):350-61.

PMID:
15170628
[PubMed - indexed for MEDLINE]
16.

Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.

Cavalcanti AM, Lacerda HR, Brito AM, Pereira S, Medeiros D, Oliveira S.

Mem Inst Oswaldo Cruz. 2007 Nov;102(7):785-92. Epub 2007 Dec 11.

PMID:
17992369
[PubMed - indexed for MEDLINE]
Free Article
17.

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.

Couto-Fernandez JC, Silva-de-Jesus C, Veloso VG, Rachid M, Gracie RS, Chequer-Fernandez SL, Oliveira SM, Arakaki-Sanchez D, Chequer PJ, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):73-8. Epub 2005 Apr 12.

PMID:
15867968
[PubMed - indexed for MEDLINE]
Free Article
18.

HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.

Aulicino PC, Rocco CA, Mecikovsky D, Bologna R, Mangano A, Sen L.

Antivir Ther. 2010;15(4):641-50. doi: 10.3851/IMP1571.

PMID:
20587857
[PubMed - indexed for MEDLINE]
19.

Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.

Derache A, Traore O, Koita V, Sylla A, Tubiana R, Simon A, Canestri A, Carcelain G, Katlama C, Calvez V, Cisse M, Marcelin AG.

Antivir Ther. 2007;12(1):123-9.

PMID:
17503757
[PubMed - indexed for MEDLINE]
20.

HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.

Vergne L, Diagbouga S, Kouanfack C, Aghokeng A, Butel C, Laurent C, Noumssi N, Tardy M, Sawadogo A, Drabo J, Hien H, Zekeng L, Delaporte E, Peeters M.

Antivir Ther. 2006;11(5):575-9.

PMID:
16964825
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk